$904 Million is the total value of Consonance Capital Management LP's 20 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPPI | Buy | SPECTRUM PHARMACEUTICALS INC | $122,537,000 | +714.0% | 8,709,131 | +331.0% | 13.55% | +664.0% |
| RTRX | Buy | RETROPHIN INC | $87,254,000 | +84.5% | 3,505,604 | +43.8% | 9.65% | +73.2% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $86,272,000 | -13.8% | 24,649,280 | -0.7% | 9.54% | -19.1% |
| PTCT | PTC THERAPEUTICS INC | $78,960,000 | +9.2% | 3,946,009 | 0.0% | 8.73% | +2.5% | |
| CORT | Sell | CORCEPT THERAPEUTICS INC | $74,927,000 | +9.4% | 3,882,223 | -33.1% | 8.29% | +2.7% |
| MYGN | Sell | MYRIAD GENETICS INC | $71,390,000 | -15.4% | 1,973,177 | -39.6% | 7.90% | -20.6% |
| LJPC | Sell | LA JOLLA PHARMACEUTICAL CO | $69,648,000 | +16.2% | 2,002,519 | -0.5% | 7.70% | +9.1% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $61,102,000 | – | 602,047 | +100.0% | 6.76% | – |
| AAAP | Sell | ADVANCED ACCELERATOR APPLICsponsored ads | $60,245,000 | -17.5% | 890,935 | -52.3% | 6.66% | -22.5% |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $51,824,000 | – | 1,380,134 | +100.0% | 5.73% | – |
| KERX | Sell | KERYX BIOPHARMACEUTICALS INC | $37,129,000 | -26.7% | 5,229,455 | -25.3% | 4.11% | -31.2% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $36,232,000 | +165.6% | 6,901,428 | +80.1% | 4.01% | +149.2% |
| VCEL | Buy | VERICEL CORP | $18,146,000 | +114.3% | 3,024,334 | +17.9% | 2.01% | +101.1% |
| CVRS | Sell | CORINDUS VASCULAR ROBOTICS I | $18,032,000 | -35.9% | 11,863,353 | -21.5% | 1.99% | -39.8% |
| GMED | Sell | GLOBUS MED INCcl a | $16,486,000 | -82.5% | 554,699 | -80.4% | 1.82% | -83.5% |
| ANIP | ANI PHARMACEUTICALS INC | $7,506,000 | +12.1% | 143,003 | 0.0% | 0.83% | +5.2% | |
| ADMA | ADMA BIOLOGICS INC | $3,924,000 | -16.8% | 1,273,933 | 0.0% | 0.43% | -21.8% | |
| STML | New | STEMLINE THERAPEUTICS INC | $1,126,000 | – | 101,420 | +100.0% | 0.12% | – |
| CPRX | New | CATALYST PHARMACEUTICALS INC | $931,000 | – | 369,298 | +100.0% | 0.10% | – |
| SPNE | Sell | SEASPINE HLDGS CORP | $489,000 | -20.9% | 43,627 | -18.6% | 0.05% | -26.0% |
| SBBP | Exit | STRONGBRIDGE BIOPHARMA PLC | $0 | – | -10,000 | -100.0% | -0.01% | – |
| BIOL | Exit | BIOLASE INC | $0 | – | -1,152,737 | -100.0% | -0.13% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -544,843 | -100.0% | -6.01% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -2,849,185 | -100.0% | -8.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL | 29 | Q2 2022 | 15.9% |
| ADMA BIOLOGICS INC | 27 | Q4 2020 | 2.3% |
| RETROPHIN INC | 23 | Q1 2020 | 11.3% |
| ANI PHARMACEUTICALS INC | 23 | Q3 2019 | 7.9% |
| VERICEL CORP | 21 | Q4 2019 | 5.5% |
| AMARIN CORP PLC | 14 | Q3 2019 | 14.4% |
| GLOBUS MED INC | 13 | Q2 2022 | 24.7% |
| ORTHOFIX INTL N V | 13 | Q3 2016 | 9.7% |
| PACIFIC BIOSCIENCES CALIF IN | 13 | Q4 2018 | 9.7% |
| CATALYST PHARM PARTNERS INC | 13 | Q3 2019 | 9.4% |
View Consonance Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | December 15, 2022 | 0 | 0.0% |
| ADMA BIOLOGICS, INC. | February 14, 2022 | 1,289,481 | 1.4% |
| ASSEMBLY BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| CASI Pharmaceuticals, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Cellectar Biosciences, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Gamida Cell Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| GenMark Diagnostics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Protagonist Therapeutics, IncSold out | February 14, 2022 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Consonance-HFW Acquisition Corp. | April 27, 2021 | 1,000,000 | 10.4% |
View Consonance Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-12-15 |
| SC 13D/A | 2022-12-15 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View Consonance Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.